Cancer Diagnostics
Cancer Diagnostics market is segmented by players, region (country), by Type and by Application. ... Read More
Global Cancer Pain Market Insights and Forecast to 2031
1 Study Coverage
1.1 Cancer Pain Product Introduction
1.2 Market by Type
1.2.1 Global Cancer Pain Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Opioids
1.2.3 Non-Steroidal Anti-Inflammatory Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cancer Pain Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.3.4 Hormone Therapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cancer Pain Sales Estimates and Forecasts 2017-2028
2.2 Global Cancer Pain Revenue Estimates and Forecasts 2017-2028
2.3 Global Cancer Pain Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cancer Pain Sales by Region
2.4.1 Global Cancer Pain Sales by Region (2017-2022)
2.4.2 Global Sales Cancer Pain by Region (2023-2028)
2.5 Global Cancer Pain Revenue by Region
2.5.1 Global Cancer Pain Revenue by Region (2017-2022)
2.5.2 Global Cancer Pain Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cancer Pain Sales by Manufacturers
3.1.1 Global Top Cancer Pain Manufacturers by Sales (2017-2022)
3.1.2 Global Cancer Pain Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cancer Pain in 2021
3.2 Global Cancer Pain Revenue by Manufacturers
3.2.1 Global Cancer Pain Revenue by Manufacturers (2017-2022)
3.2.2 Global Cancer Pain Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cancer Pain Revenue in 2021
3.3 Global Cancer Pain Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cancer Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cancer Pain Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cancer Pain Sales by Type
4.1.1 Global Cancer Pain Historical Sales by Type (2017-2022)
4.1.2 Global Cancer Pain Forecasted Sales by Type (2023-2028)
4.1.3 Global Cancer Pain Sales Market Share by Type (2017-2028)
4.2 Global Cancer Pain Revenue by Type
4.2.1 Global Cancer Pain Historical Revenue by Type (2017-2022)
4.2.2 Global Cancer Pain Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cancer Pain Revenue Market Share by Type (2017-2028)
4.3 Global Cancer Pain Price by Type
4.3.1 Global Cancer Pain Price by Type (2017-2022)
4.3.2 Global Cancer Pain Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cancer Pain Sales by Application
5.1.1 Global Cancer Pain Historical Sales by Application (2017-2022)
5.1.2 Global Cancer Pain Forecasted Sales by Application (2023-2028)
5.1.3 Global Cancer Pain Sales Market Share by Application (2017-2028)
5.2 Global Cancer Pain Revenue by Application
5.2.1 Global Cancer Pain Historical Revenue by Application (2017-2022)
5.2.2 Global Cancer Pain Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cancer Pain Revenue Market Share by Application (2017-2028)
5.3 Global Cancer Pain Price by Application
5.3.1 Global Cancer Pain Price by Application (2017-2022)
5.3.2 Global Cancer Pain Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cancer Pain Market Size by Type
6.1.1 North America Cancer Pain Sales by Type (2017-2028)
6.1.2 North America Cancer Pain Revenue by Type (2017-2028)
6.2 North America Cancer Pain Market Size by Application
6.2.1 North America Cancer Pain Sales by Application (2017-2028)
6.2.2 North America Cancer Pain Revenue by Application (2017-2028)
6.3 North America Cancer Pain Market Size by Country
6.3.1 North America Cancer Pain Sales by Country (2017-2028)
6.3.2 North America Cancer Pain Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cancer Pain Market Size by Type
7.1.1 Europe Cancer Pain Sales by Type (2017-2028)
7.1.2 Europe Cancer Pain Revenue by Type (2017-2028)
7.2 Europe Cancer Pain Market Size by Application
7.2.1 Europe Cancer Pain Sales by Application (2017-2028)
7.2.2 Europe Cancer Pain Revenue by Application (2017-2028)
7.3 Europe Cancer Pain Market Size by Country
7.3.1 Europe Cancer Pain Sales by Country (2017-2028)
7.3.2 Europe Cancer Pain Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cancer Pain Market Size by Type
8.1.1 Asia Pacific Cancer Pain Sales by Type (2017-2028)
8.1.2 Asia Pacific Cancer Pain Revenue by Type (2017-2028)
8.2 Asia Pacific Cancer Pain Market Size by Application
8.2.1 Asia Pacific Cancer Pain Sales by Application (2017-2028)
8.2.2 Asia Pacific Cancer Pain Revenue by Application (2017-2028)
8.3 Asia Pacific Cancer Pain Market Size by Region
8.3.1 Asia Pacific Cancer Pain Sales by Region (2017-2028)
8.3.2 Asia Pacific Cancer Pain Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cancer Pain Market Size by Type
9.1.1 Latin America Cancer Pain Sales by Type (2017-2028)
9.1.2 Latin America Cancer Pain Revenue by Type (2017-2028)
9.2 Latin America Cancer Pain Market Size by Application
9.2.1 Latin America Cancer Pain Sales by Application (2017-2028)
9.2.2 Latin America Cancer Pain Revenue by Application (2017-2028)
9.3 Latin America Cancer Pain Market Size by Country
9.3.1 Latin America Cancer Pain Sales by Country (2017-2028)
9.3.2 Latin America Cancer Pain Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cancer Pain Market Size by Type
10.1.1 Middle East and Africa Cancer Pain Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cancer Pain Revenue by Type (2017-2028)
10.2 Middle East and Africa Cancer Pain Market Size by Application
10.2.1 Middle East and Africa Cancer Pain Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cancer Pain Revenue by Application (2017-2028)
10.3 Middle East and Africa Cancer Pain Market Size by Country
10.3.1 Middle East and Africa Cancer Pain Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cancer Pain Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 BioDelivery Science
11.1.1 BioDelivery Science Corporation Information
11.1.2 BioDelivery Science Overview
11.1.3 BioDelivery Science Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 BioDelivery Science Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BioDelivery Science Recent Developments
11.2 ProStrakan Group
11.2.1 ProStrakan Group Corporation Information
11.2.2 ProStrakan Group Overview
11.2.3 ProStrakan Group Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 ProStrakan Group Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ProStrakan Group Recent Developments
11.3 Teva pharmaceuticals
11.3.1 Teva pharmaceuticals Corporation Information
11.3.2 Teva pharmaceuticals Overview
11.3.3 Teva pharmaceuticals Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teva pharmaceuticals Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva pharmaceuticals Recent Developments
11.4 Eli-Lilly
11.4.1 Eli-Lilly Corporation Information
11.4.2 Eli-Lilly Overview
11.4.3 Eli-Lilly Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli-Lilly Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli-Lilly Recent Developments
11.5 Grunenthal Group
11.5.1 Grunenthal Group Corporation Information
11.5.2 Grunenthal Group Overview
11.5.3 Grunenthal Group Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Grunenthal Group Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Grunenthal Group Recent Developments
11.6 GW Pharmaceuticals
11.6.1 GW Pharmaceuticals Corporation Information
11.6.2 GW Pharmaceuticals Overview
11.6.3 GW Pharmaceuticals Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GW Pharmaceuticals Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GW Pharmaceuticals Recent Developments
11.7 Johnson＆Johnson
11.7.1 Johnson＆Johnson Corporation Information
11.7.2 Johnson＆Johnson Overview
11.7.3 Johnson＆Johnson Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson＆Johnson Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson＆Johnson Recent Developments
11.8 Meda Pharmaceuticals
11.8.1 Meda Pharmaceuticals Corporation Information
11.8.2 Meda Pharmaceuticals Overview
11.8.3 Meda Pharmaceuticals Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Meda Pharmaceuticals Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Meda Pharmaceuticals Recent Developments
11.9 Orexo
11.9.1 Orexo Corporation Information
11.9.2 Orexo Overview
11.9.3 Orexo Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Orexo Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Orexo Recent Developments
11.10 Sanofi
11.10.1 Sanofi Corporation Information
11.10.2 Sanofi Overview
11.10.3 Sanofi Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sanofi Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sanofi Recent Developments
11.11 WEX Pharmaceuticals
11.11.1 WEX Pharmaceuticals Corporation Information
11.11.2 WEX Pharmaceuticals Overview
11.11.3 WEX Pharmaceuticals Cancer Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 WEX Pharmaceuticals Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 WEX Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cancer Pain Industry Chain Analysis
12.2 Cancer Pain Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cancer Pain Production Mode & Process
12.4 Cancer Pain Sales and Marketing
12.4.1 Cancer Pain Sales Channels
12.4.2 Cancer Pain Distributors
12.5 Cancer Pain Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cancer Pain Industry Trends
13.2 Cancer Pain Market Drivers
13.3 Cancer Pain Market Challenges
13.4 Cancer Pain Market Restraints
14 Key Findings in The Global Cancer Pain Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Cancer Pain Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Opioids
Table 3. Major Manufacturers of Non-Steroidal Anti-Inflammatory Drugs
Table 4. Major Manufacturers of Others
Table 5. Global Cancer Pain Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Cancer Pain Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Cancer Pain Sales by Region (2017-2022) & (K Units)
Table 8. Global Cancer Pain Sales Market Share by Region (2017-2022)
Table 9. Global Cancer Pain Sales by Region (2023-2028) & (K Units)
Table 10. Global Cancer Pain Sales Market Share by Region (2023-2028)
Table 11. Global Cancer Pain Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Cancer Pain Revenue Market Share by Region (2017-2022)
Table 13. Global Cancer Pain Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Cancer Pain Revenue Market Share by Region (2023-2028)
Table 15. Global Cancer Pain Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Cancer Pain Sales Share by Manufacturers (2017-2022)
Table 17. Global Cancer Pain Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Cancer Pain Revenue Share by Manufacturers (2017-2022)
Table 19. Cancer Pain Price by Manufacturers (2017-2022) &(USD/Unit)
Table 20. Global Cancer Pain Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Cancer Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Pain as of 2021)
Table 22. Cancer Pain Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Cancer Pain Product Offered
Table 24. Date of Manufacturers Enter into Cancer Pain Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Pain Sales by Type (2017-2022) & (K Units)
Table 27. Global Cancer Pain Sales by Type (2023-2028) & (K Units)
Table 28. Global Cancer Pain Sales Share by Type (2017-2022)
Table 29. Global Cancer Pain Sales Share by Type (2023-2028)
Table 30. Global Cancer Pain Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Cancer Pain Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Cancer Pain Revenue Share by Type (2017-2022)
Table 33. Global Cancer Pain Revenue Share by Type (2023-2028)
Table 34. Cancer Pain Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Cancer Pain Price Forecast by Type (2023-2028) & (USD/Unit)
Table 36. Global Cancer Pain Sales by Application (2017-2022) & (K Units)
Table 37. Global Cancer Pain Sales by Application (2023-2028) & (K Units)
Table 38. Global Cancer Pain Sales Share by Application (2017-2022)
Table 39. Global Cancer Pain Sales Share by Application (2023-2028)
Table 40. Global Cancer Pain Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Cancer Pain Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Cancer Pain Revenue Share by Application (2017-2022)
Table 43. Global Cancer Pain Revenue Share by Application (2023-2028)
Table 44. Cancer Pain Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Cancer Pain Price Forecast by Application (2023-2028) & (USD/Unit)
Table 46. North America Cancer Pain Sales by Type (2017-2022) & (K Units)
Table 47. North America Cancer Pain Sales by Type (2023-2028) & (K Units)
Table 48. North America Cancer Pain Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Cancer Pain Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Cancer Pain Sales by Application (2017-2022) & (K Units)
Table 51. North America Cancer Pain Sales by Application (2023-2028) & (K Units)
Table 52. North America Cancer Pain Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Cancer Pain Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Cancer Pain Sales by Country (2017-2022) & (K Units)
Table 55. North America Cancer Pain Sales by Country (2023-2028) & (K Units)
Table 56. North America Cancer Pain Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Cancer Pain Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Cancer Pain Sales by Type (2017-2022) & (K Units)
Table 59. Europe Cancer Pain Sales by Type (2023-2028) & (K Units)
Table 60. Europe Cancer Pain Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Cancer Pain Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Cancer Pain Sales by Application (2017-2022) & (K Units)
Table 63. Europe Cancer Pain Sales by Application (2023-2028) & (K Units)
Table 64. Europe Cancer Pain Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Cancer Pain Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Cancer Pain Sales by Country (2017-2022) & (K Units)
Table 67. Europe Cancer Pain Sales by Country (2023-2028) & (K Units)
Table 68. Europe Cancer Pain Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Cancer Pain Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Cancer Pain Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Cancer Pain Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Cancer Pain Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Cancer Pain Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Cancer Pain Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Cancer Pain Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Cancer Pain Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Cancer Pain Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Cancer Pain Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Cancer Pain Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Cancer Pain Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Cancer Pain Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Cancer Pain Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Cancer Pain Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Cancer Pain Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Cancer Pain Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Cancer Pain Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Cancer Pain Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Cancer Pain Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Cancer Pain Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Cancer Pain Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Cancer Pain Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Cancer Pain Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Cancer Pain Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Cancer Pain Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Cancer Pain Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Cancer Pain Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Cancer Pain Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Cancer Pain Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Cancer Pain Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Cancer Pain Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Cancer Pain Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Cancer Pain Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Cancer Pain Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Cancer Pain Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Cancer Pain Revenue by Country (2023-2028) & (US$ Million)
Table 106. BioDelivery Science Corporation Information
Table 107. BioDelivery Science Description and Major Businesses
Table 108. BioDelivery Science Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 109. BioDelivery Science Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. BioDelivery Science Recent Developments
Table 111. ProStrakan Group Corporation Information
Table 112. ProStrakan Group Description and Major Businesses
Table 113. ProStrakan Group Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. ProStrakan Group Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. ProStrakan Group Recent Developments
Table 116. Teva pharmaceuticals Corporation Information
Table 117. Teva pharmaceuticals Description and Major Businesses
Table 118. Teva pharmaceuticals Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. Teva pharmaceuticals Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Teva pharmaceuticals Recent Developments
Table 121. Eli-Lilly Corporation Information
Table 122. Eli-Lilly Description and Major Businesses
Table 123. Eli-Lilly Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 124. Eli-Lilly Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Eli-Lilly Recent Developments
Table 126. Grunenthal Group Corporation Information
Table 127. Grunenthal Group Description and Major Businesses
Table 128. Grunenthal Group Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 129. Grunenthal Group Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Grunenthal Group Recent Developments
Table 131. GW Pharmaceuticals Corporation Information
Table 132. GW Pharmaceuticals Description and Major Businesses
Table 133. GW Pharmaceuticals Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 134. GW Pharmaceuticals Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. GW Pharmaceuticals Recent Developments
Table 136. Johnson＆Johnson Corporation Information
Table 137. Johnson＆Johnson Description and Major Businesses
Table 138. Johnson＆Johnson Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 139. Johnson＆Johnson Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Johnson＆Johnson Recent Developments
Table 141. Meda Pharmaceuticals Corporation Information
Table 142. Meda Pharmaceuticals Description and Major Businesses
Table 143. Meda Pharmaceuticals Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 144. Meda Pharmaceuticals Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Meda Pharmaceuticals Recent Developments
Table 146. Orexo Corporation Information
Table 147. Orexo Description and Major Businesses
Table 148. Orexo Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 149. Orexo Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Orexo Recent Developments
Table 151. Sanofi Corporation Information
Table 152. Sanofi Description and Major Businesses
Table 153. Sanofi Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 154. Sanofi Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Sanofi Recent Developments
Table 156. WEX Pharmaceuticals Corporation Information
Table 157. WEX Pharmaceuticals Description and Major Businesses
Table 158. WEX Pharmaceuticals Cancer Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 159. WEX Pharmaceuticals Cancer Pain Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. WEX Pharmaceuticals Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Cancer Pain Distributors List
Table 164. Cancer Pain Customers List
Table 165. Cancer Pain Market Trends
Table 166. Cancer Pain Market Drivers
Table 167. Cancer Pain Market Challenges
Table 168. Cancer Pain Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Pain Product Picture
Figure 3. Global Cancer Pain Market Share by Type in 2021 & 2028
Figure 3. Opioids Product Picture
Figure 4. Non-Steroidal Anti-Inflammatory Drugs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Cancer Pain Market Share by Application in 2021 & 2028
Figure 7. Radiotherapy
Figure 8. Chemotherapy
Figure 9. Hormone Therapy
Figure 10. Others
Figure 11. Cancer Pain Report Years Considered
Figure 12. Global Cancer Pain Sales 2017-2028 (K Units)
Figure 13. Global Cancer Pain Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Cancer Pain Revenue 2017-2028 (US$ Million)
Figure 15. Global Cancer Pain Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Cancer Pain Sales Market Share by Region (2017-2022)
Figure 17. Global Cancer Pain Sales Market Share by Region (2023-2028)
Figure 18. North America Cancer Pain Sales YoY (2017-2028) & (K Units)
Figure 19. North America Cancer Pain Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Cancer Pain Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Cancer Pain Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Cancer Pain Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Cancer Pain Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Cancer Pain Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Cancer Pain Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Cancer Pain Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Cancer Pain Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Cancer Pain Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Cancer Pain in the World: Market Share by Cancer Pain Revenue in 2021
Figure 30. Global Cancer Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Cancer Pain Sales Market Share by Type (2017-2028)
Figure 32. Global Cancer Pain Revenue Market Share by Type (2017-2028)
Figure 33. Global Cancer Pain Sales Market Share by Application (2017-2028)
Figure 34. Global Cancer Pain Revenue Market Share by Application (2017-2028)
Figure 35. North America Cancer Pain Sales Market Share by Type (2017-2028)
Figure 36. North America Cancer Pain Revenue Market Share by Type (2017-2028)
Figure 37. North America Cancer Pain Sales Market Share by Application (2017-2028)
Figure 38. North America Cancer Pain Revenue Market Share by Application (2017-2028)
Figure 39. North America Cancer Pain Sales Share by Country (2017-2028)
Figure 40. North America Cancer Pain Revenue Share by Country (2017-2028)
Figure 41. U.S. Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Cancer Pain Sales Market Share by Type (2017-2028)
Figure 44. Europe Cancer Pain Revenue Market Share by Type (2017-2028)
Figure 45. Europe Cancer Pain Sales Market Share by Application (2017-2028)
Figure 46. Europe Cancer Pain Revenue Market Share by Application (2017-2028)
Figure 47. Europe Cancer Pain Sales Share by Country (2017-2028)
Figure 48. Europe Cancer Pain Revenue Share by Country (2017-2028)
Figure 49. Germany Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 50. France Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Cancer Pain Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Cancer Pain Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Cancer Pain Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Cancer Pain Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Cancer Pain Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Cancer Pain Revenue Share by Region (2017-2028)
Figure 60. China Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 63. India Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Cancer Pain Sales Market Share by Type (2017-2028)
Figure 71. Latin America Cancer Pain Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Cancer Pain Sales Market Share by Application (2017-2028)
Figure 73. Latin America Cancer Pain Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Cancer Pain Sales Share by Country (2017-2028)
Figure 75. Latin America Cancer Pain Revenue Share by Country (2017-2028)
Figure 76. Mexico Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Cancer Pain Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Cancer Pain Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Cancer Pain Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Cancer Pain Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Cancer Pain Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Cancer Pain Revenue Share by Country (2017-2028)
Figure 85. Turkey Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Cancer Pain Revenue (2017-2028) & (US$ Million)
Figure 88. Cancer Pain Value Chain
Figure 89. Cancer Pain Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BioDelivery Science ProStrakan Group Teva pharmaceuticals Eli-Lilly Grunenthal Group GW Pharmaceuticals Johnson＆Johnson Meda Pharmaceuticals Orexo Sanofi WEX Pharmaceuticals